{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:36:26Z","timestamp":1790062586631,"version":"4.0.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,7,7]],"date-time":"2014-07-07T00:00:00Z","timestamp":1404691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2014,7,7]],"date-time":"2014-07-07T00:00:00Z","timestamp":1404691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Although Alzheimer\u2019s disease (AD) is associated with early death, its life expectancy differs greatly between patients. A better understanding of this heterogeneity may reveal important disease mechanisms underlying the malignancy of AD. The aim of this study was to examine the relation between AD pathologies and early death in AD caused by dementia.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>At a memory clinic, 247 referred consecutive patients with AD were monitored during 12.6\u2009\u00b1\u20091.6 years. Multivariate Cox regression analyses were performed with baseline measures of amyloid beta (A\u03b2) pathology (<jats:italic>APOE<\/jats:italic> genotype, cerebrospinal fluid (CSF) A\u03b242) tau pathology (CSF phosphorylated tau and total tau), cerebrovascular pathology (white-matter lesions and CSF\/serum albumin ratio), neuroinflammatory pathology (CSF soluble vascular cell adhesion molecule-1, sVCAM-1), frontal, temporal, and central brain atrophies, global cognition, sex, and age. Comorbidities and medications also were analyzed. All continuous variables were transformed to <jats:italic>z<\/jats:italic> scores to compare hazard ratios (HRs) and 95% confidence intervals (CIs).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>At follow-up, 89% of the patients had died. The mean survival time was 6.4\u2009\u00b1\u20093.0 years. The AD pathology that independently predicted an early death caused by dementia was cerebral inflammation (sVCAM-1; HR, 1.32; 95% CI, 1.07\u20131.64). Other independent predictors were lower global cognition (HR, 0.51; 95% CI, 0.43\u20130.61), frontal atrophy (HR, 1.38; 95% CI, 1.12\u20131.70), and medial temporal atrophy (HR, 1.23; 95% CI, 1.02\u20131.49). When examining death caused by dementia and related causes (vascular diseases and infections), age (HR, 1.23; 95% CI, 1.04\u20131.46) and cerebrovascular pathology (white-matter lesions: HR, 1.17; 95% CI, 1.01\u20131.36; and CSF\/serum albumin ratio: HR, 1.16; 95% CI, 1.001\u20131.34) were also significant risk factors in addition to the previous variables. No comorbidity or medication was significant in the specific-cause models.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>This is the first study to link neuroinflammation independently to early death in AD and, hence, a rapidly progressing disease. Frontal and medial temporal atrophies and low cognition were also significant predictors. These are probably downstream biomarkers that reflect neuronal degeneration and late-stage disease. Our results suggest that inflammation, and not amyloid or tau pathology, is an independent underlying mechanism in the malignancy of AD.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/alzrt271","type":"journal-article","created":{"date-parts":[[2014,7,7]],"date-time":"2014-07-07T09:01:26Z","timestamp":1404723686000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Cerebral inflammation is an underlying mechanism of early death in Alzheimer\u2019s disease: a 13-year cause-specific multivariate mortality study"],"prefix":"10.1186","volume":"6","author":[{"given":"Katarina","family":"N\u00e4gga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Wattmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars-Olof","family":"Wahlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Palmqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,7]]},"reference":[{"key":"224_CR1","first-page":"S16","volume":"54","author":"C Jagger","year":"2000","unstructured":"Jagger C, Andersen K, Breteler MM, Copeland JR, Helmer C, Baldereschi M, Fratiglioni L, Lobo A, Soininen H, Hofman A, Launer LJ: Prognosis with dementia in Europe: a collaborative study of population-based cohorts: Neurologic Diseases in the Elderly Research Group. Neurology. 2000, 54: S16-S20.","journal-title":"Neurology"},{"key":"224_CR2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3233\/JAD-2012-120808","volume":"33","author":"E Lonnroos","year":"2013","unstructured":"Lonnroos E, Kyyronen P, Bell JS, van der Cammen TJ, Hartikainen S: Risk of death among persons with Alzheimer\u2019s disease: a national register-based nested case\u2013control study. J Alzheimers Dis. 2013, 33: 157-164.","journal-title":"J Alzheimers Dis"},{"key":"224_CR3","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/archneur.62.5.779","volume":"62","author":"M Ganguli","year":"2005","unstructured":"Ganguli M, Dodge HH, Shen C, Pandav RS, DeKosky ST: Alzheimer disease and mortality: a 15-year epidemiological study. Arch Neurol. 2005, 62: 779-784.","journal-title":"Arch Neurol"},{"key":"224_CR4","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1177\/0891988707301864","volume":"20","author":"PH Tsai","year":"2007","unstructured":"Tsai PH, Chen SP, Lin KN, Wang PN, Wang HC, Liu CY, Hong CJ, Liu HC: Survival of ethnic Chinese with Alzheimer\u2019s disease: a 5-year longitudinal study in Taiwan. J Geriatr Psychiatry Neurol. 2007, 20: 172-177.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"224_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1097\/WAD.0b013e31819fe7d1","volume":"24","author":"HM Arrighi","year":"2010","unstructured":"Arrighi HM, Neumann PJ, Lieberburg IM, Townsend RJ: Lethality of Alzheimer disease and its impact on nursing home placement. Alzheimer Dis Assoc Disord. 2010, 24: 90-95.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"224_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jalz.2012.02.001","volume":"8","author":"Association As","year":"2012","unstructured":"Association As: Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2012, 8: 131-168.","journal-title":"Alzheimers Dement"},{"key":"224_CR7","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0895-4356(99)00067-0","volume":"52","author":"H Aguero-Torres","year":"1999","unstructured":"Aguero-Torres H, Fratiglioni L, Guo Z, Viitanen M, Winblad B: Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases. J Clin Epidemiol. 1999, 52: 737-743.","journal-title":"J Clin Epidemiol"},{"key":"224_CR8","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S0895-4356(01)00498-X","volume":"55","author":"ED Eaker","year":"2002","unstructured":"Eaker ED, Vierkant RA, Mickel SF: Predictors of nursing home admission and\/or death in incident Alzheimer\u2019s disease and other dementia cases compared to controls: a population-based study. J Clin Epidemiol. 2002, 55: 462-468.","journal-title":"J Clin Epidemiol"},{"key":"224_CR9","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1001\/archneur.59.11.1764","volume":"59","author":"R Brookmeyer","year":"2002","unstructured":"Brookmeyer R, Corrada MM, Curriero FC, Kawas C: Survival following a diagnosis of Alzheimer disease. Arch Neurol. 2002, 59: 1764-1767.","journal-title":"Arch Neurol"},{"key":"224_CR10","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1212\/01.wnl.0000334278.11022.42","volume":"71","author":"EP Helzner","year":"2008","unstructured":"Helzner EP, Scarmeas N, Cosentino S, Tang MX, Schupf N, Stern Y: Survival in Alzheimer disease: a multiethnic, population-based study of incident cases. Neurology. 2008, 71: 1489-1495.","journal-title":"Neurology"},{"key":"224_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/ageing\/26.5.401","volume":"26","author":"BM Thomas","year":"1997","unstructured":"Thomas BM, Starr JM, Whalley LJ: Death certification in treated cases of presenile Alzheimer\u2019s disease and vascular dementia in Scotland. Age Ageing. 1997, 26: 401-406.","journal-title":"Age Ageing"},{"key":"224_CR12","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/gps.419","volume":"16","author":"A Ueki","year":"2001","unstructured":"Ueki A, Shinjo H, Shimode H, Nakajima T, Morita Y: Factors associated with mortality in patients with early-onset Alzheimer\u2019s disease: a five-year longitudinal study. Int J Geriatr Psychiatry. 2001, 16: 810-815.","journal-title":"Int J Geriatr Psychiatry"},{"key":"224_CR13","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.1468-1331.2008.02503.x","volume":"16","author":"HR Brunnstrom","year":"2009","unstructured":"Brunnstrom HR, Englund EM: Cause of death in patients with dementia disorders. Eur J Neurol. 2009, 16: 488-492.","journal-title":"Eur J Neurol"},{"key":"224_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1600-0404.1986.tb04634.x","volume":"74","author":"PK M\u00f6ls\u00e4","year":"1986","unstructured":"M\u00f6ls\u00e4 PK, Marttila RJ, Rinne UK: Survival and cause of death in Alzheimer\u2019s disease and multi-infarct dementia. Acta Neurol Scand. 1986, 74: 103-107.","journal-title":"Acta Neurol Scand"},{"key":"224_CR15","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/gps.930070703","volume":"7","author":"D Ryan","year":"1992","unstructured":"Ryan D: Death in dementia: a study of causes of death in dementia patients and their spouses. Int J Geriatr Psychiatry. 1992, 7: 465-472.","journal-title":"Int J Geriatr Psychiatry"},{"key":"224_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00401-010-0718-6","volume":"120","author":"C Iadecola","year":"2010","unstructured":"Iadecola C: The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol. 2010, 120: 287-296.","journal-title":"Acta Neuropathol"},{"key":"224_CR17","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, Shaw LM, Vemuri P, Wiste HJ, Weigand SD, Lesnick TG, Pankratz VS, Donohue MC, Trojanowski JQ: Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013, 12: 207-216.","journal-title":"Lancet Neurol"},{"key":"224_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/alzrt24","volume":"2","author":"E Zotova","year":"2010","unstructured":"Zotova E, Nicoll JA, Kalaria R, Holmes C, Boche D: Inflammation in Alzheimer\u2019s disease: relevance to pathogenesis and therapy. Alzheimers Res Ther. 2010, 2: 1-","journal-title":"Alzheimers Res Ther"},{"key":"224_CR19","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1093\/brain\/awt171","volume":"136","author":"BG Perez-Nievas","year":"2013","unstructured":"Perez-Nievas BG, Stein TD, Tai HC, Dols-Icardo O, Scotton TC, Barroeta-Espar I, Fernandez-Carballo L, de Munain EL, Perez J, Marquie M, Serrano-Pozo A, Frosch MP, Lowe V, Parisi JE, Petersen RC, Ikonomovic MD, Lopez OL, Klunk W, Hyman BT, Gomez-Isla T: Dissecting phenotypic traits linked to human resilience to Alzheimer\u2019s pathology. Brain. 2013, 136: 2510-2526.","journal-title":"Brain"},{"key":"224_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.nbd.2006.11.011","volume":"26","author":"HM Nielsen","year":"2007","unstructured":"Nielsen HM, Londos E, Minthon L, Janciauskiene SM: Soluble adhesion molecules and angiotensin-converting enzyme in dementia. Neurobiol Dis. 2007, 26: 27-35.","journal-title":"Neurobiol Dis"},{"key":"224_CR21","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology. 1984, 34: 939-944.","journal-title":"Neurology"},{"key":"224_CR22","volume-title":"Manual of the International Statistical Classification of Diseases and Health Related Problems. 10th revision","author":"World Health Organization","year":"1992","unstructured":"World Health Organization: Manual of the International Statistical Classification of Diseases and Health Related Problems. 10th revision. 1992, Geneva, Switzerland: World Health Organization"},{"key":"224_CR23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1373\/clinchem.2004.039347","volume":"51","author":"A Olsson","year":"2005","unstructured":"Olsson A, Vanderstichele H, Andreasen N, De Meyer G, Wallin A, Holmberg B, Rosengren L, Vanmechelen E, Blennow K: Simultaneous measurement of beta-amyloid (1\u201342), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology. Clin Chem. 2005, 51: 336-345.","journal-title":"Clin Chem"},{"key":"224_CR24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrneurol.2010.4","volume":"6","author":"K Blennow","year":"2010","unstructured":"Blennow K, Hampel H, Weiner M, Zetterberg H: Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol. 2010, 6: 131-144.","journal-title":"Nat Rev Neurol"},{"key":"224_CR25","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1161\/01.STR.32.6.1318","volume":"32","author":"L Wahlund","year":"2001","unstructured":"Wahlund L, Barkhof F, Fazekas F, Bronge L, Augustin M, Sj\u00f6gren M, Wallin A, Ader H, Leys D, Pantoni L, Pasquier F, Erkinjuntti T, Scheltens P: A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001, 32: 1318-1322.","journal-title":"Stroke"},{"key":"224_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1159\/000335778","volume":"32","author":"S Palmqvist","year":"2011","unstructured":"Palmqvist S, Sarwari A, Wattmo C, Bronge L, Zhang Y, Wahlund LO, Nagga K: Association between subcortical lesions and behavioral and psychological symptoms in patients with Alzheimer\u2019s disease. Dement Geriatr Cogn Disord. 2011, 32: 417-423.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"224_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s12640-010-9175-1","volume":"18","author":"JL Whitwell","year":"2010","unstructured":"Whitwell JL: Progression of atrophy in Alzheimer\u2019s disease and related disorders. Neurotox Res. 2010, 18: 339-346.","journal-title":"Neurotox Res"},{"key":"224_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/02841850701753706","volume":"49","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Londos E, Minthon L, Wattmo C, Liu H, Aspelin P, Wahlund LO: Usefulness of computed tomography linear measurements in diagnosing Alzheimer\u2019s disease. Acta Radiol. 2008, 49: 91-97.","journal-title":"Acta Radiol"},{"key":"224_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR: \u201cMini-mental state:\u201d a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975, 12: 189-198.","journal-title":"J Psychiatr Res"},{"key":"224_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/alzrt118","volume":"4","author":"P Eikelenboom","year":"2012","unstructured":"Eikelenboom P, Hoozemans JJ, Veerhuis R, van Exel E, Rozemuller AJ, van Gool WA: Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer\u2019s disease. Alzheimers Res Ther. 2012, 4: 15-","journal-title":"Alzheimers Res Ther"},{"key":"224_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2012.236","volume":"9","author":"D Krstic","year":"2013","unstructured":"Krstic D, Knuesel I: Deciphering the mechanism underlying late-onset Alzheimer disease. Nat Rev Neurol. 2013, 9: 25-34.","journal-title":"Nat Rev Neurol"},{"key":"224_CR32","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/13550280290100969","volume":"8","author":"PL McGeer","year":"2002","unstructured":"McGeer PL, McGeer EG: Local neuroinflammation and the progression of Alzheimer\u2019s disease. J Neurovirol. 2002, 8: 529-538.","journal-title":"J Neurovirol"},{"key":"224_CR33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/alzrt29","volume":"2","author":"ZS Tan","year":"2010","unstructured":"Tan ZS, Seshadri S: Inflammation in the Alzheimer\u2019s disease cascade: culprit or innocent bystander?. Alzheimers Res Ther. 2010, 2: 6-","journal-title":"Alzheimers Res Ther"},{"key":"224_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1742-2094-9-151","volume":"9","author":"D Krstic","year":"2012","unstructured":"Krstic D, Madhusudan A, Doehner J, Vogel P, Notter T, Imhof C, Manalastas A, Hilfiker M, Pfister S, Schwerdel C, Riether C, Meyer U, Knuesel I: Systemic immune challenges trigger and drive Alzheimer-like neuropathology in mice. J Neuroinflamm. 2012, 9: 151-","journal-title":"J Neuroinflamm"},{"key":"224_CR35","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.archger.2008.03.011","volume":"48","author":"C Forasassi","year":"2009","unstructured":"Forasassi C, Golmard JL, Pautas E, Piette F, Myara I, Raynaud-Simon A: Inflammation and disability as risk factors for mortality in elderly acute care patients. Arch Gerontol Geriatr. 2009, 48: 406-410.","journal-title":"Arch Gerontol Geriatr"},{"key":"224_CR36","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1161\/STROKEAHA.108.516286","volume":"40","author":"WJ Henneman","year":"2009","unstructured":"Henneman WJ, Sluimer JD, Cordonnier C, Baak MM, Scheltens P, Barkhof F, van der Flier WM: MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population. Stroke. 2009, 40: 492-498.","journal-title":"Stroke"},{"key":"224_CR37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1055\/s-0029-1223473","volume":"37","author":"SD Hotte","year":"2010","unstructured":"Hotte SD, Lankers D, Kissler S, Freyberger HJ, Schroder SG: MMSE for survival prognostics in dementia. Psychiatr Prax. 2010, 37: 78-83.","journal-title":"Psychiatr Prax"},{"key":"224_CR38","doi-asserted-by":"publisher","first-page":"501","DOI":"10.7326\/0003-4819-140-7-200404060-00008","volume":"140","author":"EB Larson","year":"2004","unstructured":"Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, Kukull WA: Survival after initial diagnosis of Alzheimer disease. Ann Intern Med. 2004, 140: 501-509.","journal-title":"Ann Intern Med"},{"key":"224_CR39","doi-asserted-by":"publisher","first-page":"429","DOI":"10.7326\/0003-4819-113-6-429","volume":"113","author":"JS Walsh","year":"1990","unstructured":"Walsh JS, Welch HG, Larson EB: Survival of outpatients with Alzheimer-type dementia. Ann Intern Med. 1990, 113: 429-434.","journal-title":"Ann Intern Med"},{"key":"224_CR40","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1159\/000319533","volume":"30","author":"M Musicco","year":"2010","unstructured":"Musicco M, Salamone G, Caltagirone C, Cravello L, Fadda L, Lupo F, Mosti S, Perri R, Palmer K: Neuropsychological predictors of rapidly progressing patients with Alzheimer\u2019s disease. Dement Geriatr Cogn Disord. 2010, 30: 219-228.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"224_CR41","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1001\/archneur.62.10.1601","volume":"62","author":"N Scarmeas","year":"2005","unstructured":"Scarmeas N, Brandt J, Albert M, Hadjigeorgiou G, Papadimitriou A, Dubois B, Sarazin M, Devanand D, Honig L, Marder K, Bell K, Wegesin D, Blacker D, Stern Y: Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Arch Neurol. 2005, 62: 1601-1608.","journal-title":"Arch Neurol"},{"key":"224_CR42","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","volume":"294","author":"LS Schneider","year":"2005","unstructured":"Schneider LS, Dagerman KS, Insel P: Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005, 294: 1934-1943.","journal-title":"JAMA"},{"key":"224_CR43","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1017\/S1041610211002924","volume":"24","author":"H Brodaty","year":"2012","unstructured":"Brodaty H, Seeher K, Gibson L: Dementia time to death: a systematic literature review on survival time and years of life lost in people with dementia. Int Psychogeriatr. 2012, 24: 1034-1045.","journal-title":"Int Psychogeriatr"},{"key":"224_CR44","first-page":"2608","volume":"300","author":"M Wachterman","year":"2008","unstructured":"Wachterman M, Kiely DK, Mitchell SL: Reporting dementia on the death certificates of nursing home residents dying with end-stage dementia. JAMA. 2008, 300: 2608-2610.","journal-title":"JAMA"},{"key":"224_CR45","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4103\/1817-1745.57326","volume":"4","author":"SM Jaber","year":"2009","unstructured":"Jaber SM, Hamed EA, Hamed SA: Adhesion molecule levels in serum and cerebrospinal fluid in children with bacterial meningitis and sepsis. J Pediatr Neurosci. 2009, 4: 76-85.","journal-title":"J Pediatr Neurosci"},{"key":"224_CR46","doi-asserted-by":"publisher","first-page":"520","DOI":"10.4049\/jimmunol.170.1.520","volume":"170","author":"WG James","year":"2003","unstructured":"James WG, Bullard DC, Hickey MJ: Critical role of the alpha 4 integrin\/VCAM-1 pathway in cerebral leukocyte trafficking in lupus-prone MRL\/fas(lpr) mice. J Immunol. 2003, 170: 520-527.","journal-title":"J Immunol"},{"key":"224_CR47","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.4049\/jimmunol.161.9.4992","volume":"161","author":"JW Oh","year":"1998","unstructured":"Oh JW, Van Wagoner NJ, Rose-John S, Benveniste EN: Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression. J Immunol. 1998, 161: 4992-4999.","journal-title":"J Immunol"},{"key":"224_CR48","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/135245859800400317","volume":"4","author":"P Rieckmann","year":"1998","unstructured":"Rieckmann P, Altenhofen B, Riegel A, Kallmann B, Felgenhauer K: Correlation of soluble adhesion molecules in blood and cerebrospinal fluid with magnetic resonance imaging activity in patients with multiple sclerosis. Mult Scler. 1998, 4: 178-182.","journal-title":"Mult Scler"},{"key":"224_CR49","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cardiores.2005.02.020","volume":"67","author":"RJ Singh","year":"2005","unstructured":"Singh RJ, Mason JC, Lidington EA, Edwards DR, Nuttall RK, Khokha R, Knauper V, Murphy G, Gavrilovic J: Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1) ectodomain release is regulated by TIMP-3. Cardiovasc Res. 2005, 67: 39-49.","journal-title":"Cardiovasc Res"},{"key":"224_CR50","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1001\/archneurol.2011.148","volume":"68","author":"A Uzawa","year":"2011","unstructured":"Uzawa A, Mori M, Masuda S, Kuwabara S: Markedly elevated soluble intercellular adhesion molecule 1, soluble vascular cell adhesion molecule 1 levels, and blood\u2013brain barrier breakdown in neuromyelitis optica. Arch Neurol. 2011, 68: 913-917.","journal-title":"Arch Neurol"},{"key":"224_CR51","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1172\/JCI11871","volume":"107","author":"MI Cybulsky","year":"2001","unstructured":"Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connelly PW, Milstone DS: A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest. 2001, 107: 1255-1262.","journal-title":"J Clin Invest"},{"key":"224_CR52","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1016\/j.neurobiolaging.2011.04.008","volume":"33","author":"RP Rouhl","year":"2012","unstructured":"Rouhl RP, Damoiseaux JG, Lodder J, Theunissen RO, Knottnerus IL, Staals J, Henskens LH, Kroon AA, de Leeuw PW, Tervaert JW, van Oostenbrugge RJ: Vascular inflammation in cerebral small vessel disease. Neurobiol Aging. 2012, 33: 1800-1806.","journal-title":"Neurobiol Aging"},{"key":"224_CR53","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1212\/01.WNL.0000094327.68399.59","volume":"61","author":"JS Hui","year":"2003","unstructured":"Hui JS, Wilson RS, Bennett DA, Bienias JL, Gilley DW, Evans DA: Rate of cognitive decline and mortality in Alzheimer\u2019s disease. Neurology. 2003, 61: 1356-1361.","journal-title":"Neurology"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/alzrt271.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/alzrt271\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/alzrt271.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:04:03Z","timestamp":1728921843000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/alzrt271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,7]]},"references-count":53,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,8]]}},"alternative-id":["224"],"URL":"https:\/\/doi.org\/10.1186\/alzrt271","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,7]]},"assertion":[{"value":"30 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"41"}}